Clinical Trials Logo

Complement 3 Glomerulopathy clinical trials

View clinical trials related to Complement 3 Glomerulopathy.

Filter by:
  • Available  
  • Page 1

NCT ID: NCT04729062 Available - C3 Glomerulopathy Clinical Trials

C3G/Primary IC-MPGN EAP

Start date: n/a
Phase:
Study type: Expanded Access

This is an Early Access Program (EAP) which will provide access to pegcetacoplan for eligible participants with C3G and Primary IC-MPGN.